Section : News
Early Diagnosis and treatment of Alzheimer’s disease (AD) may be one step closer thanks to new research conducted at the Douglas Mental Health University Institute. The study, authored by Rémi Quirion PhD, scientific director of the D
Section : News
The Douglas Institute is part of an international effort to investigate a new treatment A vaccine-based approach could be an effective therapy for people with mild or moderate forms of Alzheimer’s disease. The medication used for this therapy w
Section : News
McGill, MUHC and Douglas researchers, among them Alain Brunet, get top marks from Québec Science
Section : News
Imagine if: A patient’s file indicates that he has been receiving treatment and a team is handling his follow-up care – fourteen months after he died. You see patients’ names on a waiting list when, in fact, they a
Section : News
Like all other healthcare establishments, the Douglas Institute follows the guidelines issued by the Ministry of Health and Social Services (MSSS). The Pandemic Plan has been deployed across the Institute and the Pandemic Plan Management Committee has
Section : News
Douglas Institute researchers and students took part in the Eureka! Festival, which was held at the Quays of the Old Port of Montréal on June 14-16. They held a booth on the topic of "Brain Behaviour Revealed." For the first time
Section : News
Voici maintenant quatre mois que je suis revenu d'Angleterre. Je dresse ici un bilan des expériences anglaises dont, il me semble, le Québec pourrait s'inspirer.
Section : News
Over the past 2 years, the Douglas has been working on a project to renew its physical infrastructure. This process has been driven by the increasing number of obstacles the aging facilities present to delivering against the organization’s multi
Section : News
Forensic mental health researcher Anne Crocker, PhD, is tackling some of today's most challenging mental health policy questions.
Section : News
The Douglas Institute recently inaugurated its new Neurophenotyping Centre.